| Basic data |
|---|
| OCA1. Surname awarded to the assessed person | Prokeš |
|---|
| OCA2. Name awarded to the assessed person | Marián |
|---|
| OCA3. Degrees awarded to the assessed person | Assoc. prof. , DVM, PhD |
|---|
| OCA4. Hyperlink to the entry of the person in the Register of university staff | https://www.portalvs.sk/regzam/detail/6118 |
|---|
| OCA5. Area of assessment | study programme man-animal relationship and its use in canistherapy and hipotherapy · I. degree |
|---|
| OCA6. Category of the research/artistic/other output | |
|---|
| OCA7. Year of publication of the research/artistic/other output | 2025 |
|---|
| OCA8. ID of the record in the Central Registry of Publication Activity (CRPA) or the Central Registry of Artistic Activity (CRAA) | 1423405 |
|---|
| OCA9. Hyperlink to the record in CRPA or CRAA | https://app.crepc.sk/?fn=detailBiblioForm&sid=83712EB9BC21748F2E9B5B10A71B |
|---|
| Characteristics of the output that is not registered in CRPA or CRAA |
|---|
| OCA10. Hyperlink to the record in another publicly accessible register, catalogue of research/ artistic/other outputs | https://www.scopus.com/pages/publications/105013035388?origin=resultslist |
|---|
| OCA11. Characteristics of the output in the format of the CRPA or the CRAA bibliographic record, if the output is not available in a publicly accessible register or catalogue of outputs | Antiadhesive effects of exopolysaccharides isolated from Limosilactobacillus reuteri |
|---|
| OCA12. Type of the output (if the output is not registered in CRPA or CRAA) | article |
|---|
| OCA13. Hyperlink to the webpage where the output is available (full text, other documentation, etc.) | https://office2.jmbfs.org/index.php/JMBFS/article/view/11574 |
|---|
| OCA14. Characteristics of the author's contribution | Editing the article. |
|---|
| OCA15. Annotation of the output with contextual information concerning the description of creative process and the content of the research/artistic/other activity, etc. | Probiotics with their biological properties and products contribute to optimal functioning of organ systems and form a natural barrier against the growth of undesirable microorganisms. Exopolysaccharides (EPS) isolated from selected strains of Lactobacilli are tested for their antiadhesive, anti-biofilm and other beneficial effects. EPS isolated from the SL16 strain of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) significantly reduced adhesion of Staphylococcus aureus CCM 3953 and Proteus mirabilis CCM 7188, and this effect was directly proportional to EPS concentration and stronger against S. aureus CCM 3953. Achieved results indicated an anti-biofilm potential of EPS obtained from intestinal Lactobacilli, probably attributable to antiadhesive activity of the tested EPS. Further studies will be required in order to clarify a mechanism of the anti-biofilm effect at the molecular level. Within the research into innovative anti-biofilm agents (biodegradable and non-toxic), the results obtained may facilitate the development of more efficient procedures or preparations that will be used in pharmacotherapy. |
|---|
| Other data |
|---|
| OCA16. Annotation of the output in English | Probiotics with their biological properties and products contribute to optimal functioning of organ systems and form a natural barrier against the growth of undesirable microorganisms. Exopolysaccharides (EPS) isolated from selected strains of Lactobacilli are tested for their antiadhesive, anti-biofilm and other beneficial effects. EPS isolated from the SL16 strain of Limosilactobacillus reuteri (formerly Lactobacillus reuteri) significantly reduced adhesion of Staphylococcus aureus CCM 3953 and Proteus mirabilis CCM 7188, and this effect was directly proportional to EPS concentration and stronger against S. aureus CCM 3953. Achieved results indicated an anti-biofilm potential of EPS obtained from intestinal Lactobacilli, probably attributable to antiadhesive activity of the tested EPS. Further studies will be required in order to clarify a mechanism of the anti-biofilm effect at the molecular level. Within the research into innovative anti-biofilm agents (biodegradable and non-toxic), the results obtained may facilitate the development of more efficient procedures or preparations that will be used in pharmacotherapy. |
|---|
| OCA17. List of maximum 5 most significant citations corresponding to the output | Ismail, N. I., Nawawi, K. N. M., Hsin, D. C. C., Hao, K. W., Mahmood, N. R. K. N., Chearn, G. L. C., Wong, Z., Tamil, A. M., Joseph, H., & Raja Ali, R. A. (2023). Probiotic containing Lactobacillus reuteri DSM 17648 as an adjunct treatment for Helicobacter pylori infection: A randomized, double-blind, placebo-controlled trial. Helicobacter, 28(6), e13017. https://doi.org/10.1111/hel.13017 |
|---|
| OCA18. Characteristics of the output's impact on socio-economic practice | Within the research into innovative anti-biofilm agents (biodegradable and non-toxic), the results obtained may facilitate the development of more efficient procedures or preparations that will be used in pharmacotherapy. |
|---|
| OCA19. Characteristics of the output and related activities' impact on the educational process | The impacts and results of the work will be reflected in the teaching of study subjects with an epizootiological content. |
|---|